Cell therapy/device combo for diabetes treatment is in the works

01/10/2013 | MedCityNews.com

Sernova is working on a polymer "cell pouch" system infused with therapeutic islet cells that can administer insulin based on a diabetes patient's blood glucose levels. The device, implanted below the skin in the abdomen using a 15-minute procedure, also will contain the Sertolin local immune protection cell system to prevent transplant rejection.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health